NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/19/2024
Back to search
Official data from USPTO
STATIN OVERPRESCRIBING SOLUTION (S.O.S.)
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
STATIN OVERPRESCRIBING SOLUTION (S.O.S.)
ST13
US500000098038802Class
44
Filing
98038802
Registration
7568461
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
15
Latest update
11/19/2024
Trademark type
Word
Nice classes
44
Filing date
06/12/2023
Registration date
11/19/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/19/2024
Last transaction
11/19/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
05/12/2023
First use in commerce
05/12/2023
Drawing code
4
Owner type
01
Owner location
Mineola, NY, US
Examiner
ADEYIGA, ADETAYO JANET
Law office
L90
Current location
TMEG LAW OFFICE 109
Holders and representatives
Holders
R. D. (pessoa física)
Representatives
Jae Youn Kim NOVICK, KIM & LEE, DBA NKL LAW
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Medical servicesproviding a program for lowering cholesterol levels naturally; Medical servicesproviding a personalized cholesterol-lowering program involving detoxgenetically-guided evaluation for optimal macronutrients and micronutrients balanceexercise type and durationmedication and supplement optimization; Providing integrativeholistic care to patients involving geneticsenvironmentalnutritionalbehavioralexercise evaluationby making bespoke recommendations to patients regarding nutritional supplements for the prevention and treatment of chronic conditionsinflammationdysregulated metabolism; Medical servicesproviding a personalized cholesterol-lowering program to patients with the assistance of artificial intelligencemachine learningdata analysis in the fields of bloodbiomarkergenetic assessmentsmetabolic typingevidence-based guidelines of practiceenvironmentalnutritionalbehavioralexercise evaluationhealth screenings and disease diagnosistreatment efficacy predictions and evaluations; Providing medical advice to patients involving geneticsenvironmentalnutritionalbehavioralexercise evaluationby making bespoke recommendations to patients regarding nutritional supplements for prevention and treatment of chronic conditionsinflammationdysregulated metabolism
Publications
History of USPTO decisions and trademark events.
15 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
11/19/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/03/2024
PUBO
PUBLISHED FOR OPPOSITION
09/03/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/14/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/31/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/20/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/20/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/20/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/21/2024
GNRT
NON-FINAL ACTION E-MAILED
02/21/2024
CNRT
NON-FINAL ACTION WRITTEN
02/21/2024
DOCK
ASSIGNED TO EXAMINER
02/14/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/17/2023
NWAP
NEW APPLICATION ENTERED
06/15/2023
Continuous trademark protection
Get notified about every new filing that threatens STATIN OVERPRESCRIBING SOLUTION (S.O.S.) or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.